ARTICLE
6 October 2026

New: PBM Policy And Legislative Update

M
Mintz

Contributor

Mintz is a litigation powerhouse and business accelerator serving leaders in life sciences, private equity, sustainable energy, and technology. The world’s most innovative companies trust Mintz to provide expert advice, protect and monetize their IP, negotiate deals, source financing, and solve complex legal challenges. The firm has over 600 attorneys across offices in Boston, Los Angeles, Miami, New York, Washington, DC, San Francisco, San Diego, and Toronto.
Mintz’s Managed Care, PBMs & Pharmacies Practice is pleased to present its quarterly publication, PBM Policy and Legislative Update. This issue examines key federal and state developments from mid-February 2026 through June 2026 impacting PBMs and the broader prescription drug supply chain.
United States Food, Drugs, Healthcare, Life Sciences

Mintz’s Managed Care, PBMs & Pharmacies Practice is pleased to present its quarterly publication, PBM Policy and Legislative Update. This issue examines key federal and state developments from mid-February 2026 through June 2026 impacting PBMs and the broader prescription drug supply chain. 

Highlights include: 

  • Federal and state legislative activity, regulatory and enforcement developments, and significant litigation
  • Emerging market trends affecting PBMs, health plans, pharmacies, manufacturers, and other industry stakeholders

To view the full article please click here.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

[View Source]
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More